ET Healthcare vs Tempus

Side-by-side comparison of AI visibility scores, market position, and capabilities

Tempus leads in AI visibility (74 vs 35)
ET Healthcare logo

ET Healthcare

NicheLife Sciences & BioTech

Isotachophoresis-Based Sample Preparation for Diagnostics & Research

ET Healthcare develops isotachophoresis (ITP) technology for rapid, automated nucleic acid and biomarker sample preparation in life sciences research and diagnostics; enables faster processing with minimal sample volumes;

AI VisibilityBeta
Overall Score
D35
Category Rank
#159 of 198
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
35
Gemini
29

About

ET Healthcare is a Menlo Park, California-based life sciences instrumentation company that develops sample preparation technology based on isotachophoresis (ITP) — an electrokinetic technique that concentrates and purifies nucleic acids, proteins, and other biomolecules from complex biological samples without centrifugation or column-based purification steps. ITP uses electric fields to focus and separate analytes by their electrophoretic mobility, enabling very rapid (often sub-10-minute) purification from small sample volumes with minimal hands-on steps.

Full profile
Tempus logo

Tempus

LeaderLife Sciences & BioTech

AI-Enabled Precision Medicine

Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.

AI VisibilityBeta
Overall Score
B74
Category Rank
#11 of 198
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
71
Perplexity
68
Gemini
80

About

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.

Full profile

AI Visibility Head-to-Head

35
Overall Score
74
#159
Category Rank
#11
68
AI Consensus
68
stable
Trend
stable
39
ChatGPT
71
35
Perplexity
68
29
Gemini
80
40
Claude
77
29
Grok
69

Key Details

Category
Isotachophoresis-Based Sample Preparation for Diagnostics & Research
AI-Enabled Precision Medicine
Tier
Niche
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.